Randomized phase II study of cetuximab in combination with cisplatin (C) and vinorelbine (V) vs. CV alone in the first-line treatment of patients (pts) with epidermal growth factor receptor (EGFR)-expressing advanced non-small-cell lung cancer (NSCLC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7012-7012
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7012-7012
◽
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7537-7537
◽
Keyword(s):
2014 ◽
Vol 32
(8)
◽
pp. 859-863
◽
2017 ◽
Vol 35
(6)
◽
pp. 692-692
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7024-7024
◽
2011 ◽
Vol 9
(1)
◽
pp. 2
◽